PL1796717T3 - Szczepionka skojarzona - Google Patents

Szczepionka skojarzona

Info

Publication number
PL1796717T3
PL1796717T3 PL05803574T PL05803574T PL1796717T3 PL 1796717 T3 PL1796717 T3 PL 1796717T3 PL 05803574 T PL05803574 T PL 05803574T PL 05803574 T PL05803574 T PL 05803574T PL 1796717 T3 PL1796717 T3 PL 1796717T3
Authority
PL
Poland
Prior art keywords
antigen
combination vaccine
relates
combination
confer
Prior art date
Application number
PL05803574T
Other languages
English (en)
Inventor
Michael Bröker
Original Assignee
Novartis Vaccines And Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines And Diagnostics Gmbh filed Critical Novartis Vaccines And Diagnostics Gmbh
Publication of PL1796717T3 publication Critical patent/PL1796717T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL05803574T 2004-10-08 2005-10-07 Szczepionka skojarzona PL1796717T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04024103A EP1645283A1 (en) 2004-10-08 2004-10-08 Combination vaccine
PCT/EP2005/010845 WO2006037658A1 (en) 2004-10-08 2005-10-07 Combination vaccine
EP05803574A EP1796717B1 (en) 2004-10-08 2005-10-07 Combination vaccine

Publications (1)

Publication Number Publication Date
PL1796717T3 true PL1796717T3 (pl) 2012-08-31

Family

ID=34926925

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05803574T PL1796717T3 (pl) 2004-10-08 2005-10-07 Szczepionka skojarzona

Country Status (8)

Country Link
US (1) US20090130146A1 (pl)
EP (2) EP1645283A1 (pl)
JP (1) JP2008515842A (pl)
AT (1) ATE547116T1 (pl)
CA (1) CA2583221A1 (pl)
DK (1) DK1796717T3 (pl)
PL (1) PL1796717T3 (pl)
WO (1) WO2006037658A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2144998T (pt) * 2007-04-06 2017-04-07 Takeda Vaccines Inc Métodos e composições para vírus vivos atenuados
GB0905570D0 (en) * 2009-03-31 2009-05-13 Novartis Ag Combined vaccines
MX2011002071A (es) * 2008-08-29 2011-04-05 Boehringer Ingelheim Vetmed Vacuna para el virus del nilo occidental.
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
CN102655879B (zh) * 2009-12-16 2016-03-09 印度血清研究所 疫苗组合物
CA2862864C (en) * 2011-01-13 2018-12-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2829226C (en) 2011-03-14 2023-01-03 Boehringer Ingelheim Vetmedica, Inc. Equine rhinitis vaccine
WO2012163289A1 (zh) 2011-06-01 2012-12-06 厦门大学 包含白喉毒素无毒突变体crm197或其片段的融合蛋白
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
EP2802353A4 (en) 2012-01-12 2015-12-02 Variation Biotechnologies Inc COMPOSITIONS AND METHOD FOR THE TREATMENT OF VIRUS INFECTIONS
CN104244984B (zh) 2012-01-27 2020-03-31 变异生物技术公司 用于治疗剂的方法和组合物
WO2014059313A1 (en) * 2012-10-12 2014-04-17 Lehigh University Thermally stable enzymes, compositions thereof and methods of using same
KR20240145520A (ko) * 2022-03-18 2024-10-07 덴카 주식회사 링커에 의해 연결된 캡시드 단백질을 포함하는 바이러스 유사입자

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT405940B (de) * 1996-06-21 1999-12-27 Immuno Ag Verfahren zur gewinnung und reinigung von rekombinantem, nicht-lipidiertem osp-protein

Also Published As

Publication number Publication date
EP1796717B1 (en) 2012-02-29
EP1645283A1 (en) 2006-04-12
EP1796717A1 (en) 2007-06-20
WO2006037658A1 (en) 2006-04-13
CA2583221A1 (en) 2006-04-13
ATE547116T1 (de) 2012-03-15
DK1796717T3 (da) 2012-05-29
JP2008515842A (ja) 2008-05-15
US20090130146A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
SI2097102T1 (sl) Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus
PL1796717T3 (pl) Szczepionka skojarzona
SI1951296T2 (sl) Iz celic izpeljana virusna cepiva z nizko stopnjo preostale celiäśne dna z obdelavo z betapropiolaktonom
TW200806316A (en) Yeast-based vaccine for inducing an immune response
PH12011502633A1 (en) Vaccines and methods to treat canine influenza
NZ607477A (en) Non-natural amino acid replication-dependent microorganisms and vaccines
SG156652A1 (en) Yeast-based therapeutic for chronic hepatitis c infection
MX341842B (es) Virus de la influenza capaces de infectar canidos y usos de los mismos.
WO2007002470A3 (en) Inactivated chimeric vaccines and related methods of use
AU2017261706A1 (en) Inactivating pathogens and producing highly immunogenic inactivated vaccines using a dual oxidation process
MY153290A (en) Multivalent avian influenza vaccines
ATE508185T1 (de) Virosomenpartikel mit antigenen aus influenzavirus und hepatitis-b-virus
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
UA97376C2 (uk) Вакцина
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
WO2011050431A3 (pt) Vacina de dna contra o vírus da febre amarela
UA4626U (uk) Бівалентна інактивована концентрат-вакцина проти інфекційного ринотрахеїту та вірусної діареї великої рогатої худоби
WO2006006165A3 (en) Use of erythropoietin for enhancing immune responses and for treatment of lymphoproliferative disorders
SG159529A1 (en) Vaccine
ATE491469T1 (de) Zusammensetzung mit einem kolloidalen synthetischen bioresorbierbaren vektor und einem viralen vektor
UA34800U (ru) Способ коррекции клеточных показателей иммунитета у взрослых больных вирусным гепатитом а с наличием вторичных иммунодефицитных состояний
TH81792A (th) วัคซีน
UA6097U (en) Process for preparation of multivac vaccine for prevention and treatment of widespread infectious diseases of animals caused by infectious associated etiologic agent